Axillary lymph node (ALN) status is an important prognostic factor in the assessment of new breast cancer patients and therapy planning.It is currently dete
The identification and enumeration of tumor cells circulating in the peripheral blood (CTCs) of individuals with metastatic breast cancer has proven to be o
Introduction: HER-2 overexpression, a predictive marker of tumor aggressiveness and responsiveness to therapy,occurs in 20-30% of breast cancer.Although bre